title: Triamcinolone acetonide in ocular therapeutics.
abstract: Triamcinolone acetonide has been effectively used in ocular therapeutics for over 50 years. Its use has increased dramatically in recent years for periocular and intraocular treatment of retinal vasculature disease and uveitis. This comprehensive review discusses the pharmacokinetics of triamcinolone acetonide and summarizes its uses in a number of diseases, both intraocular and extraocular. It discusses side effects and their management. Finally, it discusses the controversy over its use.
authors: Tulane University Health Sciences Center, New Orleans, Louisiana, USA.
authors: C M
authors: CM
authors: Jermak
authors: J T
authors: JT
authors: Dellacroce
authors: J
authors: J
authors: Heffez
authors: G A
authors: GA
authors: Peyman
mesh_terms: D005938:Glucocorticoids / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D007637:Keratoconjunctivitis / Q000188:drug therapy; D008269:Macular Edema / Q000188:drug therapy; D012164:Retinal Diseases / Q000188:drug therapy; D014222:Triamcinolone Acetonide / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014605:Uveitis / Q000188:drug therapy
chemical_list: D005938:Glucocorticoids; D014222:Triamcinolone Acetonide